Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Colonic Neoplasms"" wg kryterium: Temat


Tytuł :
Feasibility of Pooled One-Step Nucleic Acid Amplification for Molecular Staging of Pathologically Node-Negative Colon Cancer: A Prospective Multicenter Study.
Autorzy :
Tani K; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Itabashi M; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan. .
Okuya K; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Okita K; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Takemasa I; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo, Hokkaido, Japan.
Tomita N; Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.; Cancer Treatment Center, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
Ogawa S; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Nagashima Y; Department of Surgical Pathology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Yamamoto M; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (13), pp. 8804-8812. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Colonic Neoplasms*/genetics
Colonic Neoplasms*/pathology
Nucleic Acids*
Feasibility Studies ; Humans ; Keratin-19/genetics ; Lymph Nodes/pathology ; Neoplasm Staging ; Nucleic Acid Amplification Techniques ; Prospective Studies ; Sentinel Lymph Node Biopsy
Czasopismo naukowe
Tytuł :
Delayed surgical resection of primary left-sided obstructing colon cancer is associated with improved short- and long-term outcomes.
Autorzy :
de Roos MAJ; Department of Gastrointestinal Surgery and Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
Hugen N; Department of Gastrointestinal Surgery and Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
Hazebroek EJ; Department of Gastrointestinal Surgery and Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
Spillenaar Bilgen EJ; Department of Gastrointestinal Surgery and Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Dec; Vol. 124 (7), pp. 1146-1153. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Time-to-Treatment*
Colonic Neoplasms/*mortality
Intestinal Obstruction/*mortality
Intestinal Obstruction/*surgery
Aged ; Anastomosis, Surgical ; Chemotherapy, Adjuvant/statistics & numerical data ; Colonic Neoplasms/complications ; Colonic Neoplasms/therapy ; Female ; Humans ; Intestinal Obstruction/etiology ; Male ; Neoadjuvant Therapy/statistics & numerical data ; Prognosis ; Registries ; Retrospective Studies ; Self Expandable Metallic Stents
Czasopismo naukowe
Tytuł :
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer.
Autorzy :
Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: .
Argilés G; Luis Diaz Laboratory, MSKCC, Sloan Kettering Institute, New York, USA.
Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Martinelli E; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Taniguchi H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Arnold D; Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany.
Mishima S; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Li Y; Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Smruti BK; Department of Medical Oncology, Lilavati Hospital and Research Centre and Bombay Hospital, Mumbai, India.
Ahn JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Seoul, Korea.
Faud I; Department of Radiotherapy & Oncology, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
Yeh KH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Lin PC; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chua C; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Hasbullah HH; Oncology Unit, Faculty of Medicine, UiTM Sg Buloh, Selangor, Malaysia.
Lee MA; Division of Medical Oncology, Department of Internal Medicine, Cancer Research Institute, College of Medicine, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Sun Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Curigliano G; Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy.
Bando H; Department of Clinical Oncology, Aichi Cancer Center, Nagoya, Japan.
Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center, Leipzig University Medical Center, Leipzig, Germany.
Yamanaka T; Department of Biostatistics, Yokohama City University, Kanagawa, Japan.
Tabernero J; Department of Medical Oncology, Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Cervantes A; CIBERONC, Department of Medical Oncology, Institute of Health Research, INCLIVIA, University of Valencia, Valencia, Spain.
Ohtsu A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Peters S; Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Ishioka C; Department of Clinical Oncology, Tohoku University School of Medicine, Sendai, Japan.
Pentheroudakis G; ESMO, Lugano, Switzerland.
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1496-1510. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonic Neoplasms*/diagnosis
Colonic Neoplasms*/therapy
Medical Oncology*
Asia/epidemiology ; Follow-Up Studies ; Humans ; Republic of Korea
Raport
Tytuł :
Piclamilast mitigates 1,2-dimethylhydrazine induced colon cancer in rats through modulation of Ras/PI3K/Akt/mTOR and NF-κβ signaling.
Autorzy :
Abdel-Wahab BA; Department of Pharmacology, College of Pharmacy, Najran University, Kingdom of Saudi Arabia; Department of Medical Pharmacology, College of Medicine, Assiut University, Assiut, Egypt. Electronic address: .
Alqhtani H; Department of Clinical Pharmacy, College of Pharmacy, Najran University, Kingdom of Saudi Arabia.
Walbi IA; Department of Clinical Pharmacy, College of Pharmacy, Najran University, Kingdom of Saudi Arabia.
Albarqi HA; Department of Pharmaceutics, College of Pharmacy, Najran University, Kingdom of Saudi Arabia.
Aljadaan AM; Department of Pharmacology, College of Pharmacy, Najran University, Kingdom of Saudi Arabia; School of Medicine, University of Nottingham, United Kingdom.
Khateeb MM; Department of Pharmacology, College of Pharmacy, Najran University, Kingdom of Saudi Arabia.
Hassanein EHM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Egypt.
Pokaż więcej
Źródło :
Chemico-biological interactions [Chem Biol Interact] 2021 Dec 01; Vol. 350, pp. 109686. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji :
Journal Article
MeSH Terms :
1,2-Dimethylhydrazine/*antagonists & inhibitors
1,2-Dimethylhydrazine/*toxicity
Benzamides/*pharmacology
Colonic Neoplasms/*drug therapy
Colonic Neoplasms/*metabolism
Phosphodiesterase 4 Inhibitors/*pharmacology
Pyridines/*pharmacology
Aberrant Crypt Foci/drug therapy ; Aberrant Crypt Foci/metabolism ; Aberrant Crypt Foci/pathology ; Animals ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Proliferation/drug effects ; Colonic Neoplasms/chemically induced ; Disease Models, Animal ; Male ; Oxidative Stress/drug effects ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Rats ; Rats, Wistar ; Signal Transduction/drug effects ; TOR Serine-Threonine Kinases/metabolism ; ras Proteins/metabolism
Czasopismo naukowe
Tytuł :
Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature.
Autorzy :
Zou Y; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.; Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.
Liu S; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.; Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.
Wu J; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.; Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China.
Sun Z; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China. .; Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei, China. .
Pokaż więcej
Źródło :
World journal of surgical oncology [World J Surg Oncol] 2021 Nov 22; Vol. 19 (1), pp. 332. Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/surgery
Fluorouracil*/adverse effects
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Capecitabine/adverse effects ; Chemotherapy, Adjuvant/adverse effects ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Ileum ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data.
Autorzy :
Cheng CY; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
Datzmann T; Center for Evidence-based Healthcare (ZEGV), University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Hernandez D; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schmitt J; Center for Evidence-based Healthcare (ZEGV), University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Schlander M; Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.; Alfred Weber Institute, University of Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Nov 15; Vol. 149 (10), pp. 1744-1754. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hospitals*
Colonic Neoplasms/*economics
Cost-Benefit Analysis/*methods
Delivery of Health Care/*economics
Health Care Costs/*statistics & numerical data
Algorithms ; Certification ; Cohort Studies ; Colonic Neoplasms/diagnosis ; Colonic Neoplasms/therapy ; Germany ; Humans ; Kaplan-Meier Estimate ; Models, Economic ; Prognosis ; Time Factors
Czasopismo naukowe
Tytuł :
[Tumour deposition (TD), a probably underestimated poor prognostic criterion, to be taken into account in the therapeutic management of patients with stage III colon cancer].
Autorzy :
Delattre JF; Sorbonne Université, AP-HP, Service d'Oncologie Médicale, Hôpital Saint-Antoine, Paris, France.
Cohen R; Sorbonne Université, AP-HP, Service d'Oncologie Médicale, Hôpital Saint-Antoine, Paris, France.
Emile JF; Service d'Anatomie et Cytologie Pathologiques, Hôpital Ambroise Paré (AP-HP), EA4340-BECCOH, Université de Versailles, Université Paris-Saclay, Boulogne, France.
Bibeau F; Service d'Anatomie et Cytologie Pathologiques, CHU de Caen, Université Caen Normandie, France.
Broudin C; Service d'Anatomie et Cytologie Pathologiques, Hôpital Européen Georges-Pompidou, AP-HP, Paris, Université de Paris, Paris, France.
Taieb J; Service de gastroentérologie et d'oncologie gastro-intestinale, Hôpital Européen Georges-Pompidou, AP-HP, Université de Paris, Paris, France.
André T; Sorbonne Université, AP-HP, Service d'Oncologie Médicale, Hôpital Saint-Antoine, Paris, France.
Svrcek M; Sorbonne Université, AP-HP, Service d'Anatomie et Cytologie Pathologiques, Hôpital St Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France. Electronic address: .
Pokaż więcej
Transliterated Title :
Les dépôts tumoraux (DT), un critère pronostique péjoratif probablement sous-estimé, à prendre en compte dans la prise en charge thérapeutique des malades atteints de cancer colique de stade III.
Źródło :
Annales de pathologie [Ann Pathol] 2021 Nov; Vol. 41 (6), pp. 535-543. Date of Electronic Publication: 2021 Oct 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Colonic Neoplasms*/diagnosis
Colonic Neoplasms*/pathology
Colonic Neoplasms*/therapy
Colorectal Neoplasms*/pathology
Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł :
Colon cancer patients with mismatch repair deficiency are more likely to present as acute surgical cases.
Autorzy :
Gkekas I; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. Electronic address: .
Novotny J; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Kaprio T; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Finland.
Beilmann-Lehtonen I; Department of Transplantation and Liver Surgery, University of Helsinki and Helsinki University Hospital, Finland.
Fabian P; Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Edin S; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Strigård K; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Svoboda T; Department of Oncology and Radiotherapy, Faculty Hospital Pilsen, Charles University, Prague, Czech Republic.
Hagström J; Department of Pathology, University of Helsinki, Finland; Department of Oral Pathology and Radiology, University of Turku, Finland.
Barsova L; Comprehensive Oncology Center, Liberec, Czech Republic.
Jirasek T; Department of Pathology, Liberec, Czech Republic.
Haglund C; Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Finland.
Palmqvist R; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Gunnarsson U; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Nov; Vol. 157, pp. 1-9. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms/*complications
Colonic Neoplasms/*genetics
Colonic Neoplasms/*surgery
Colorectal Neoplasms/*complications
Neoplastic Syndromes, Hereditary/*complications
Adult ; Aged ; Aged, 80 and over ; Colonic Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review.
Autorzy :
Akahoshi S; Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Yamamura K; Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Komohara Y; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; .
Yoshii D; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Oda E; Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Sato N; Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Yuki H; Department of Radiology, Yamaga City Medical Center, Kumamoto, Japan.
Yukimura K; Yukimura Clinic, Kumamoto, Japan.
Beppu T; Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Nov; Vol. 41 (11), pp. 5847-5854.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Neoplasms, Second Primary*
Tumor Escape*
B7-H1 Antigen/*analysis
Biomarkers, Tumor/*analysis
Carcinoma, Adenosquamous/*immunology
Colonic Neoplasms/*immunology
Aged ; Carcinoma, Adenosquamous/pathology ; Carcinoma, Adenosquamous/surgery ; Colectomy ; Colonic Neoplasms/pathology ; Colonic Neoplasms/surgery ; Female ; Humans ; Neoplasm Staging ; Treatment Outcome ; Up-Regulation
Czasopismo naukowe
Tytuł :
Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists.
Autorzy :
Lang-Schwarz C; Institute of Pathology, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany. .; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany. .
Melcher B; Institute of Pathology, Koblenz, Franz-Weis-Str. 13, 56073, Koblenz, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany.
Bertz S; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany.
Dregelies T; Institute of Pathology, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany.
Lang-Schwarz K; Department of Anesthesiology, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany.
Vieth M; Institute of Pathology, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany.; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany.
Sterlacci W; Institute of Pathology, Klinikum Bayreuth, Preuschwitzer Str. 101, 95445, Bayreuth, Germany.; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054, Erlangen, Germany.
Pokaż więcej
Źródło :
International journal of colorectal disease [Int J Colorectal Dis] 2021 Nov; Vol. 36 (11), pp. 2497-2510. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
B7-H1 Antigen*
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/immunology
Tumor Microenvironment*
Lymphocytes, Tumor-Infiltrating/*immunology
Biomarkers, Tumor ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Large-scale prospective genome-wide association study of oxaliplatin in stage II/III colon cancer and neuropathy.
Autorzy :
Kanai M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: .
Kawaguchi T; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan.
Manaka D; Department of Surgery, Gastrointestinal Center, Kyoto-Katsura Hospital, Kyoto, Japan.
Hasegawa J; Department of Surgery, Osaka Rosai Hospital, Osaka, Japan.
Takagane A; Department of Surgery, Hakodate Goryoukaku Hospital, Hokkaido, Japan.
Munemoto Y; Department of Surgery, Fukui Ken Saiseikai Hospital, Fukui, Japan.
Kato T; Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan.
Eto T; Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Touyama T; Department of Surgery, Nakagami Hospital, Okinawa, Japan.
Matsui T; Department of Gastroenterological Surgery, Aichi Cancer Center Aichi Hospital, Aichi, Japan.
Shinozaki K; Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Matsumoto S; Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Mizushima T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Mori M; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
Sakamoto J; Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan; Tokai Central Hospital, Kakamigahara, Japan.
Ohtsu A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
Saji S; Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan.
Matsuda F; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Nov; Vol. 32 (11), pp. 1434-1441. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/genetics
Genome-Wide Association Study*
Antineoplastic Combined Chemotherapy Protocols ; Chemotherapy, Adjuvant ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Fluorouracil/therapeutic use ; Humans ; Neoplasm Recurrence, Local ; Oxaliplatin/adverse effects ; Prospective Studies
Czasopismo naukowe
Tytuł :
Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies.
Autorzy :
Papadimitriou N; International Agency for Research on Cancer, Lyon, France.
Gunter MJ; International Agency for Research on Cancer, Lyon, France.
Murphy N; International Agency for Research on Cancer, Lyon, France.
Gicquiau A; International Agency for Research on Cancer, Lyon, France.
Achaintre D; International Agency for Research on Cancer, Lyon, France.
Brezina S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Gumpenberger T; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Baierl A; Department of Statistics and Operations Research, University of Vienna, Vienna, Austria.
Ose J; Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
Geijsen AJMR; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
van Roekel EH; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Gsur A; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Gigic B; Division of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Habermann N; Division of Preventive Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Genome Biology, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Ulrich CM; Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
Kampman E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
Weijenberg MP; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Ueland PM; BEVITAL, Bergen, Norway.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katzke V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Krogh V; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Bueno-de-Mesquita B; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Ardanaz E; Navarra Public Health Institute, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Travis RC; Cancer Epidemiology Unit, Department of Population Health, University of Oxford, Oxford, UK.
Schulze MB; German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; Institute of Nutrition Science, University of Potsdam, Potsdam, Germany.
Sánchez MJ; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
Colorado-Yohar SM; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia.
Weiderpass E; International Agency for Research on Cancer, Lyon, France.
Scalbert A; International Agency for Research on Cancer, Lyon, France.
Keski-Rahkonen P; International Agency for Research on Cancer, Lyon, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Nov 01; Vol. 149 (9), pp. 1659-1669. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonic Neoplasms/*blood
Kynurenine/*blood
Serotonin/*blood
Tryptophan/*blood
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Colonic Neoplasms/diagnosis ; Colonic Neoplasms/metabolism ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Tryptophan/metabolism
Czasopismo naukowe
Tytuł :
Zinc Inhibits Cadherin 1 Expression Induced by 1α,25-Dihydroxyvitamin D 3 in Colon Cancer Cells.
Autorzy :
Ishizawa M; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan.
Hirayu A; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan.; Department of Applied Biological Science, Nihon University College of Bioresource Sciences, Kanagawa, Japan.
Makishima M; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan; .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Nov; Vol. 41 (11), pp. 5453-5459.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD/*metabolism
Cadherins/*metabolism
Calcitriol/*pharmacology
Chlorides/*pharmacology
Colonic Neoplasms/*metabolism
Receptors, Calcitriol/*agonists
Zinc Compounds/*pharmacology
Antigens, CD/genetics ; Cadherins/genetics ; Colonic Neoplasms/genetics ; Colonic Neoplasms/pathology ; Gene Expression Regulation, Neoplastic ; HCT116 Cells ; Humans ; Metallothionein/genetics ; Metallothionein/metabolism ; Receptors, Calcitriol/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł :
Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Autorzy :
Sun D; Department of Gastrointestinal Surgery, Affiliated Hospital of Yangzhou University, Yangzhou, 225100, People's Republic of China.
Yang KS; Department of General Surgery, People's Hospital of Jingjiang, Yangzhou University Medical Academy, Yangzhou, China.
Chen JL; Department of General Surgery, People's Hospital of Jingjiang, Yangzhou University Medical Academy, Yangzhou, China.
Wang ZB; Department of Gastrointestinal Surgery, Affiliated Hospital of Yangzhou University, Yangzhou, 225100, People's Republic of China. .
Pokaż więcej
Źródło :
World journal of surgical oncology [World J Surg Oncol] 2021 Oct 26; Vol. 19 (1), pp. 314. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*/genetics
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/genetics
Gene Expression Regulation, Neoplastic ; Humans ; Prognosis ; RNA-Binding Proteins
Czasopismo naukowe
Tytuł :
Human α-defensin 5 suppressed colon cancer growth by targeting PI3K pathway.
Autorzy :
Qiao Q; Department of Obstetrics and Gynecology, Affiliated Hospital of Inner Mongolia Medical University, No.1, Tongdao North Street, Huimin District, Hohhot, 010050, PR China. Electronic address: .
Bai R; Department of Clinical Laboratory, Inner Mongolia People's Hospital, Zhaowuda Road, Hohhot, 010018, PR China. Electronic address: .
Song W; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Gao H; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Zhang M; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Lu J; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Hong M; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Zhang X; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Sun P; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Zhang Q; Pediatric Intensive Care Unit, Affiliated Hospital of Inner Mongolia Medical University, 1#, Xinhua Street, Hohhot, 010050, PR China. Electronic address: .
Zhao P; Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Xinhua Street, Hohhot, 010059, PR China. Electronic address: .
Pokaż więcej
Źródło :
Experimental cell research [Exp Cell Res] 2021 Oct 15; Vol. 407 (2), pp. 112809. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Colonic Neoplasms/*prevention & control
Phosphatidylinositol 3-Kinases/*chemistry
alpha-Defensins/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Colonic Neoplasms/genetics ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; Female ; Humans ; Mice ; Mice, Nude ; Phosphatidylinositol 3-Kinases/metabolism ; Prognosis ; Survival Rate ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; alpha-Defensins/genetics
Czasopismo naukowe
Tytuł :
LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
Autorzy :
Xiao L; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Zhang C; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Li X; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Jia C; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Chen L; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Yuan Y; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Gao Q; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Lu Z; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Feng Y; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Zhao R; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Zhao X; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Cheng S; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Shu Z; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Xu J; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Duan W; School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
Nie G; Ukraine Joint Research Center for Nano Carbon Black, Yulin 537000, China.; Optoelectronic Information Research Center, School of Physics and Telecommunication Engineering, Yulin Normal University, Yulin 537000, China.; Guangxi Key Laboratory of Agricultural Resource Chemistry and Biotechnology, Yulin 537000, China.
Hou Y; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 08; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Movement*
Gene Expression Regulation, Neoplastic*
Adenocarcinoma/*pathology
Biomarkers, Tumor/*metabolism
Colonic Neoplasms/*pathology
Lymphoid Enhancer-Binding Factor 1/*metabolism
Actins/metabolism ; Adenocarcinoma/genetics ; Adenocarcinoma/metabolism ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Colonic Neoplasms/genetics ; Colonic Neoplasms/metabolism ; Humans ; Lymphoid Enhancer-Binding Factor 1/genetics ; Pseudopodia/metabolism ; Tubulin/metabolism ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Autorzy :
Grbčić P; Department of Biotechnology, University of Rijeka, Radmile Matejčić 2, 51000 Rijeka, Croatia.
Eichmann TO; Institute of Molecular Biosciences, University of Graz, Heinrichstraße 31/III, 8010 Graz, Austria.
Kraljević Pavelić S; Faculty of Health Studies, University of Rijeka, Viktora Cara Emina 5, 51000 Rijeka, Croatia.
Sedić M; Centre for Applied Bioanthropology, Institute for Anthropological Research, Ljudevita Gaja 32, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 05; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 05.
Typ publikacji :
Journal Article
MeSH Terms :
Adamantane/*analogs & derivatives
Biomarkers, Tumor/*antagonists & inhibitors
Colonic Neoplasms/*drug therapy
Drug Resistance, Neoplasm/*drug effects
Nuclear Proteins/*antagonists & inhibitors
Phosphotransferases (Alcohol Group Acceptor)/*antagonists & inhibitors
Pyridines/*pharmacology
Vemurafenib/*pharmacology
Adamantane/pharmacology ; Antineoplastic Agents/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Proliferation ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; Gene Expression Regulation, Neoplastic ; Humans ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Phosphotransferases (Alcohol Group Acceptor)/genetics ; Phosphotransferases (Alcohol Group Acceptor)/metabolism ; Proto-Oncogene Proteins c-akt ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis.
Autorzy :
Harewood R; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. .; Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Imperial College London, London, UK. .
Disney R; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Imperial College London, London, UK.
Kinross J; Department of Surgery and Cancer, Imperial College London, London, UK.
von Wagner C; Research Department of Behavioural Science and Health, University College London, London, UK.
Cross AJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Imperial College London, London, UK.
Pokaż więcej
Źródło :
Cancer causes & control : CCC [Cancer Causes Control] 2021 Oct; Vol. 32 (10), pp. 1047-1061. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal*
Colonic Neoplasms*/epidemiology
Colonic Neoplasms*/prevention & control
Aspirin ; Humans ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Surgical resection for a huge recurrent right colon carcinoma after cetuximab plus FOLFIRI.
Autorzy :
Chen CC; Department of Surgery, Division of Colorectal,Taichung Veterans General Hospital, Taichung City, 40705, Taiwan; Department of Environmental Engineering, Dayeh University, Changhua County, 51591, Taiwan. Electronic address: .
Chen CP; Department of Surgery, Division of Colorectal,Taichung Veterans General Hospital, Taichung City, 40705, Taiwan. Electronic address: .
Yao PC; Department of Environmental Engineering, Dayeh University, Changhua County, 51591, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Asian journal of surgery [Asian J Surg] 2021 Oct; Vol. 44 (10), pp. 1310-1311. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma*
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/surgery
Cetuximab ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/surgery
Opinia redakcyjna
Tytuł :
Structural and functional characterization explains loss of dNTPase activity of the cancer-specific R366C/H mutant SAMHD1 proteins.
Autorzy :
Bowen NE; Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Temple J; Department of Molecular Biophysics and Biochemistry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Shepard C; Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Oo A; Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Arizaga F; Department of Molecular Biophysics and Biochemistry, School of Medicine, Yale University, New Haven, Connecticut, USA.
Kapoor-Vazirani P; Department of Radiation Oncology, School of Medicine, Emory University, Atlanta, Georgia, USA.
Persaud M; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Yu CH; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Kim DH; School of Pharmacy, Kyung-Hee University, Seoul, South Korea.
Schinazi RF; Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA.
Ivanov DN; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Diaz-Griffero F; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Yu DS; Department of Radiation Oncology, School of Medicine, Emory University, Atlanta, Georgia, USA.
Xiong Y; Department of Molecular Biophysics and Biochemistry, School of Medicine, Yale University, New Haven, Connecticut, USA. Electronic address: .
Kim B; Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA; Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Electronic address: .
Pokaż więcej
Źródło :
The Journal of biological chemistry [J Biol Chem] 2021 Oct; Vol. 297 (4), pp. 101170. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Colonic Neoplasms*/enzymology
Colonic Neoplasms*/genetics
Leukemia*/enzymology
Leukemia*/genetics
Mutation, Missense*
Neoplasm Proteins*/chemistry
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
SAM Domain and HD Domain-Containing Protein 1*/chemistry
SAM Domain and HD Domain-Containing Protein 1*/genetics
SAM Domain and HD Domain-Containing Protein 1*/metabolism
Amino Acid Substitution ; Cell Line ; Cyclin A2/chemistry ; Cyclin A2/genetics ; Cyclin A2/metabolism ; DNA Breaks, Double-Stranded ; DNA Repair ; Endodeoxyribonucleases/chemistry ; Endodeoxyribonucleases/genetics ; Endodeoxyribonucleases/metabolism ; Humans ; Structure-Activity Relationship
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies